Immunophenotyping and Efficacy of Low Dose ATG in Non-Sensitized Kidney Recipients Undergoing Early Steroid Withdrawal: A Randomized Pilot Study-Reference-Cited by-同舟云学术

Immunophenotyping and Efficacy of Low Dose ATG in Non-Sensitized Kidney Recipients Undergoing Early Steroid Withdrawal: A Randomized Pilot Study

Published:2014-08-11 Issue:8 Volume:9 Page:e104408
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Grafals Monica,Smith Brian,Murakami Naoka,Trabucco Agnes,Hamill Katherine,Marangos Erick,Gilligan Hannah,Pomfret Elizabeth A.,Pomposelli James J.,Simpson Mary A.,Azzi Jamil,Najafian Nader,Riella Leonardo V.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Immunosuppressive drugs for kidney transplantation;PF Halloran;N Engl J Med,2004

2. OPTN/SRTR 2011 Annual Data Report: kidney;AJ Matas;Am J Transplant,2013

3. Immunosuppression: evolution in practice and trends, 1994–2004;HU Meier-Kriesche;Am J Transplant,2006

4. Induction immunosuppression;AD Kirk;Transplantation,2006

5. Thymoglobulin and its use in renal transplantation: a review;U Thiyagarajan;American journal of nephrology,2013

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current use of antithymoglobulin as induction regimen in kidney transplantation: A review;Medicine;2024-03-01

2. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis;Transplantation Reviews;2023-12

3. Single-dose antithymocyte globulin in standard immunological risk kidney transplant recipients: efficacy and kinetics of peripheral blood CD3+ T lymphocyte modulation;Journal of Nephrology;2023-11-09

4. Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients;Scientific Reports;2023-08-02

5. A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients;PLOS ONE;2023-03-01